Tri-N-Boc-tetraazamacrocycle-nucleoside conjugates: Synthesis and anti- HIV activities

Nucleosides and Nucleotides

Volumn 17, Issue 5, 1998, Pages 957-968

  Dessolin, J ^a,b   Vlieghe, P ^a,b   Bouygues, M ^a,b   Medou, M ^a,b   Quelever G ^a,b   Camplo, M ^a,b   Chermann, J C ^b   Kraus, J L ^a,b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; NUCLEOSIDE; TETRAAZAMACROCYCLE NUCLEOSIDE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONJUGATE; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEMBRANE FUSION; STRUCTURE ACTIVITY RELATION; VIRUS INHIBITION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0031901303     PISSN: 07328311     EISSN: None     Source Type: Journal    
DOI: 10.1080/07328319808003466     Document Type: Article

References (13)

1. Yarchoan, R.; Myers, C.E.; Mitsuya, H.; Broder, S. Clinical-pharmacology of 3′-azido- 3′-deoxythymidine (Zidovudine) and related dideoxynucleosides. N. Engl. J. Med. 1989, 321, 726-738.
2. Huang, P.; Farquhar, D.; Plunkett, W. Selective action of 3′-azido-3′-deoxythymidine-5′- triphosphate on viral reverse transcriptases and human DNA polymerases. J. Biol. Chem. 1990, 265, 1914-1918.
3. Kraus, J.L.; Camplo, M.; Mourier, N.; Patent INSERM-ZAMBON Italie, "Derivati 1,3- ossatiolanici ad attività antivirale", 1997, pending.
4. Mayaux, J.F.; Bousseau, A.; Pauwels, R.; Huet, T.; Henin, Y.; Dereu, N.; Evers, M.; Soler, F.; Poujade, C.; De Clercq, E.; Le Pecq, J.B. Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 3564-3568.
5. Boitrel, B.; Andrioletti, B.; Lachkar, M.; Guilard, R. Characterization and application of a new diprotected cyclam : a novel two-step synthesis of linked tetraazamacrocycles. Tetrahedron Lett. 1995, 36, 4995-4998.
6. Brandes, S.; Gros, C.; Denat, F.; Pullumbi, P.; Guilard, R. New facile and convenient synthesis of bispolyazamacrocycles using Boc protection : Determination of geometric parameters of dinuclear Copper (II) complexes using ESR spectroscopy and molecular mechanics calculations. Bull. Soc. Chim. Fr. 1996, 133, 65-73.
7. Aggarwal, S.K.; Gogu, S.R.; Rangan, S.R.S.; Agrawal, K.C. Synthesis and biological evaluation of prodrugs of Zidovudine. J. Med. Chem. 1990, 33, 1505-1510.
8. Rey, F.; Barré-Sinoussi, F.; Schmidtmayerova, H.; Chermann, J.C. Detection and titration of neutralizing antibodies to HIV using an inhibition of the cytopathic effect of the virus on MT-4 cells. J. Virol Methods, 1987, 16, 239-249.
9. Rey, F.; Donker, G.; Hirsch, I.; Chermann, J.C. Productive infection of CD4+ cells by selected HIV strains is not inhibited by anti-CD4 monoclonal antibodies. Virology 1991, 181, 165-171.
10. Harada, S.; Yamamoto, N.; Koyanagi, Y. Infection of HTLV-III/LAV in HTLV-1 carrying cells MT-2 and MT-4 and application in a plaque assay. Science 1985, 229, 563-566.
11. Torrence, P.F.; Kinjo, J.; Khamnei, S.; Greig, N.H. Synthesis and pharmacokinetics of a dihydropyridine chemical delivery system fot the antiimunodeficiency agent dideoxycytidine. J. Med. Chem. 1993, 36, 529-537.
12. Camplo, M.; Charvet, A.S.; Faury, P.; Wondrak, E.; Chermann, J.C.; Kraus, J.L. Synthesis and antiviral activity of a potential prodrug : N-4 retinoyl-3′-thia-2′,3′-dideoxycytidine. Med. Chem. Res. 1993, 3, 87-95.
13. Camplo, M.; Faury, P.; Charvet, A.S.; Graciet, J.C.; Chermann, J.C.; Kraus, J.L. Synthesis and comparative anti-HIV activities of new acetylated 2′,3′-dideoxy-3′-thiacytidine analogues. Eur. J. Med. Chem. 1994, 29, 357-362.